CA Patent

CA2283517A1 — Use of low molecular oligomer esters of .alpha.-hydroxy acids and/or aromatic of o-hydroxy acids in cosmetic formulations

Assigned to Merck Patent GmbH · Expires 1998-10-15 · 28y expired

What this patent protects

The invention relates to the use of low molecular oligomer esters of .alpha.hydroxy acids and/or aromatic o-hydroxy acids in cosmetic formulations, wherein the corresponding .alpha.-hydroxy acid and/or aromatic o-hydroxy acid is controllably released by hydrolysis during use.

USPTO Abstract

The invention relates to the use of low molecular oligomer esters of .alpha.hydroxy acids and/or aromatic o-hydroxy acids in cosmetic formulations, wherein the corresponding .alpha.-hydroxy acid and/or aromatic o-hydroxy acid is controllably released by hydrolysis during use.

Drugs covered by this patent

Patent Metadata

Patent number
CA2283517A1
Jurisdiction
CA
Classification
Expires
1998-10-15
Drug substance claim
No
Drug product claim
No
Assignee
Merck Patent GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.